Cost-effectiveness analysis of sentinel lymph node biopsy in the treatment of early-stage vulvar cancer

International Journal of Gynecological Cancer

Volumn 24, Issue 8, 2014, Pages 1480-1485

  Erickson, Britt K ^a,b   Divine, Laura M ^b   Leath, Charles A ^a,b   Straughn, J Michael ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cost effectiveness analysis; Inguinal femoral lymph node dissection; Postoperative complications; Sentinel lymph node biopsy; Vulvar cancer

Indexed keywords

TECHNETIUM SULFUR COLLOID TC 99M;

ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COST EFFECTIVENESS ANALYSIS; CURRENT PROCEDURAL TERMINOLOGY; CYSTIC LYMPHANGIOMA; DISEASE FREE SURVIVAL; DOSIMETRY; EARLY INTERVENTION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEALTH CARE COST; HUMAN; INGUINAL FEMORAL LYMPH NODE DISSECTION; LONG TERM SURVIVAL; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME; UNCERTAINTY; UNITED STATES; VULVA CANCER; VULVECTOMY; ADVERSE EFFECTS; CARCINOMA; COST BENEFIT ANALYSIS; ECONOMICS; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; TUMOR RECURRENCE; VULVAR NEOPLASMS;

CARCINOMA; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; VULVAR NEOPLASMS;

EID: 84923092696     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000222     Document Type: Article

References (15)

1. Levenback CF, Ali S, Coleman RL, et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol. 2012;30:3786-3791.
2. Van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884-889.
3. Hacker NF, Leuchter RS, Berek JS, et al. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol. 1981;58:574-579.
4. De Hullu JA, Hollema H, Lolkema S, et al. Vulvar carcinoma. The price of less radical surgery. Cancer. 2002;95:2331-2338.
5. DeSimone CP, Van Ness JS, Cooper AL, et al. The treatment of lateral T1 and T2 squamous cell carcinomas of the vulva confined to the labium majus or minus. Gynecol Oncol. 2007;104:390-395.
6. Oonk MH, van Hemel BM, Hollema H, et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol. 2010;11:646-652.
7. Hassanzade M, Attaran M, Treglia G, et al. Lymphatic mapping and sentinel node biopsy in squamous cell carcinoma of the vulva: systematic review and meta-analysis of the literature. Gynecol Oncol. 2013;130:237-245.
8. Ries LAG YJ, Keel GE, Eisner MP, et al. SEER Survival Monograph: cancer survival among adults: US SEER Program, 1988-2001, patient and tumor characteristics. National Cancer Institute, SEER Program, NIH 07-6215. Bethesda, MD: National Cancer Institute; 2007.
9. Bell JG, Lea JS, Reid GC. Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma. Gynecol Oncol. 2000;77:314-318.
10. Carlson JW, Kauderer J, Walker JL, et al. A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study. Gynecol Oncol. 2008;110:76-82.
11. McMasters KM, Wong SL, Chao C, et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques. Ann Surg. 2001;234:292-299 discussion 299-300.
12. Clarke D, Newcombe RG, Mansel RE, et al. The learning curve in sentinel node biopsy: the ALMANAC experience. Ann Surg Oncol. 2004;11:211S-215S.
13. Olsen MA, Chu-Ongsakul S, Brandt KE, et al. Hospital-associated costs due to surgical site infection after breast surgery. Arch Surg. 2008;143:53-60 discussion 61.
14. Boltz MM, Hollenbeak CS, Julian KG, et al. Hospital costs associated with surgical site infections in general and vascular surgery patients. Surgery. 2011;150:934-942.
15. Stout NL, Pfalzer LA, Springer B, et al. Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care. Phys Ther. 2012;92:152-163.